IMSS-Bienestar Launches Virtual Mpox Training Program

The IMSS-Bienestar Health Education System (SIESABI), in partnership with the National Center for the Prevention and Control of HIV and AIDS (CENSIDA), has launched a virtual training program focused on mpox. This initiative, supported by the PAHO, aims to equip 1,600 healthcare professionals from across Mexico with essential knowledge and skills related to mpox, covering detection, diagnosis, and treatment.?

The system facilitates the reporting of probable cases through the National Epidemiological Surveillance System platform, as reported by Mexico’s Ministry of Health (SSA). Since its inception in May 2022, this surveillance program has required all medical units nationwide to report suspected mpox cases, leading to a significant reduction in probable cases during 2023. By Aug. 24, 2024, the surveillance had identified 315 probable cases for the year, with 61 confirmed and no deaths reported.

In addition to monitoring and reporting, Mexico has implemented a detailed response plan for managing mpox. This plan includes coordination efforts, community involvement, integrated care strategies, and ongoing epidemiological surveillance.?

To prevent the spread of mpox, the SSA advises individuals to wash their hands frequently with soap and water or use an alcohol-based hand sanitizer, cover their nose and mouth with their inner elbow when sneezing or coughing, and avoid sharing food, drinks, utensils, and plates. Wearing a medical mask, washing contaminated items with warm water and detergent, and cleaning and disinfecting areas where an infected person has been are also recommended. Those experiencing symptoms are encouraged to seek medical attention promptly and avoid close contact with others.

On Aug. 14, 2024, the World Health Organization (WHO) declared a public health emergency of international concern (PHEIC), its highest global alert level, for monkeypox (mpox) for the second time in two years, as reported by MBN . The first declaration was made in July 2022. This follows the Africa Centres for Disease Control and Prevention's (CDC) declaration of a public health emergency earlier this week.

“WHO Director-General Dr. Tedros Adhanom Ghebreyesus has determined that the upsurge of mpox in the Democratic Republic of the Congo (DRC) and a growing number of countries in Africa constitutes a PHEIC under the International Health Regulations (2005),” writes WHO on LinkedIn.